Greenland Mines L…
USUSDGreenland Mines Ltd (US:GRML) — Biotechnology: Biological Products (No Diagnostic Substances). Numero di borse in cui sono quotate le azioni della società: 1. In questa pagina: prezzo e grafico, dividendi, principali azionisti e cronologia del numero di azioni.
Informazioni sull'Azienda
- Sito Web
- greenlandmines.com
- Relazioni con gli Investitori
- ir.greenlandmines.com/
- Settore
- Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
- Sede Centrale
- OMAHA, United States
- Amministratore Delegato
- Joseph A. Sinkule Pharm.D.
- Dipendenti
- 5
- Azioni in Circolazione
- 158.85 Mln al 2026-08-17
- Flottante
- 2.62 Mln
- Capitalizzazione di Mercato
- 80.88 Mln USD
- Insider
- 3.81%
- Investitori Istituzionali
- 6.34%
- Settore (SIC)
- Biological Products, (No Diagnostic Substances)
- FCF
- −14.2 Mln USD
- Debito
- 870 k USD
- Utili e FCF — per i 12 mesi a 30.06.2026 (l'ultimo rapporto dell'azienda).
Descrizione
Greenland Mines Ltd engages in the cell and gene therapy, and natural resources businesses. The company primarily explores palladium, gold, and platinum deposits. It focuses on the exploration and development of Skaergaard project located in Southeast Greenland and the Sarartoq neodymium-praseodymium (Nd-Pr) rare earths project in Southwest Greenland. The company is also involved in the development of KLTO-202, a gene therapy for the treatment and prevention of amyotrophic lateral sclerosis; and KLTO-101 for the treatment or prevention of Alzheimer's disease, as well as therapies to treat Parkinson's and other age-related disorders. The company was formerly known as Klotho Neurosciences, Inc. and changed its name to Greenland Mines Ltd in March 2026. Greenland Mines Ltd is based in Charlotte, North Carolina.
Borse e Ticker
| Borsa | Ticker | Valuta | Prezzo | Tipo |
|---|---|---|---|---|
| US USA Stocks | GRML | USD | 5.88 +0.86% | azioni ordinarie |
Principali Azionisti
| Detentore | Quota | Azioni | Data del Rapporto |
|---|---|---|---|
| SINKULE JOSEPH (Chief Ex… | ≈72.04% | 6.35 Mln | 2026-03-04 |
| LEBLANC JEFF (Chief Fina… | ≈54.72% | 4.82 Mln | 2026-07-16 |
| ZENTMAN SAMUEL M (Direct… | ≈12.33% | 1.09 Mln | 2026-03-04 |
| HIRSCHMAN SHALOM Z (Dire… | ≈10.32% | 908 873 | 2026-03-04 |
| MCGARITY JON W (Director… | ≈6.26% | 551 277 | 2026-07-20 |
| SAWYER JASON DAVID (Dire… | ≈2.72% | 240 000 | 2026-07-22 |
| EL-DADA RIAD HUSSEIN (Di… | ≈1.99% | 175 000 | 2026-06-25 |
| Meteora Capital, LLC | 1.22% | 107 475 | 2026-06-30 |
| Citadel Advisors Llc | 1.17% | 103 313 | 2026-06-30 |
| Vanguard Capital Managem… | 0.69% | 60 767 | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 0.35% | 30 956 | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 0.34% | 29 811 | 2026-06-30 |
| Geode Capital Management… | 0.23% | 20 545 | 2026-06-30 |
| Davidson Kempner Capital… | 0.23% | 20 000 | 2026-06-30 |
| Vanguard Fiduciary Trust… | 0.15% | 12 834 | 2026-06-30 |
| Fidelity Concord Street… | 0.13% | 11 444 | 2026-07-31 |
| Renaissance Technologies… | 0.1% | 9 142 | 2026-06-30 |
| State Street Corporation | 0.07% | 6 050 | 2026-06-30 |
| UBS Group AG | 0.06% | 5 285 | 2026-06-30 |
| Northern Trust Corporati… | 0.06% | 4 948 | 2026-06-30 |
| Fidelity Concord Street… | 0.04% | 3 184 | 2026-07-31 |
| Fidelity Concord Street… | 0.03% | 3 074 | 2026-07-31 |
| Fidelity Concord Street… | 0% | 350 | 2026-07-31 |
| John Hancock Variable In… | 0% | 48 | 2026-06-30 |
Accedi con Google